Dr. Nitesh D. Kuhadiya, MPH, of the State University of New York at Buffalo, and colleagues, conducted a retrospective analysis of 10 patients on continuous glucose monitoring treated with insulin, Victoza (liraglutide) and Farxiga (dapagliflozin).

Read more